NORTHWEST BIOTHERAPEUTICS INC
Clinical trial NCT05236036 updates: 1. primary completion date: 2026-01-12 → 2029-01-03 2. enrollment: 60 → 86 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05236036 updates: 1. primary completion date: 2026-01-12 → 2029-01-03 2. enrollment: 60 → 86 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical